Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure

Bone

Volumn 47, Issue 1, 2010, Pages 156-163

  Nikolov, Igor G ^a   Joki, Nobuhiko ^b   Nguyen Khoa, Thao ^b,c   Ivanovski, Ognen ^a   Phan, Olivier ^b   Lacour, Bernard ^c   Drüeke, Tilman B ^a   Massy, Ziad A ^a   dos Reis, Luciene Machado ^d   Jorgetti, Vanda ^d   Lafage Proust, Marie Hélène ^e  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITÉ JEAN MONNET   (France)

Author keywords

3 Dimensional microtomography; ApoE mouse; Atherosclerosis; Bone; Chronic renal failure; Histomorphometry; Vascular calcification

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERY CALCIFICATION; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TISSUE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FEMUR; GENOTYPE; MALE; METABOLIC BONE DISEASE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEITIS FIBROSA; OSTEOBLAST; OSTEOID; OSTEOLYSIS; PROTEIN DEPLETION; THREE DIMENSIONAL IMAGING; TRABECULAR BONE; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; BLOOD VESSELS; BODY WEIGHT; BONE AND BONES; BONE DISEASES; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; FEMALE; KIDNEY FAILURE, CHRONIC; MICE; MICE, INBRED C57BL; MINERALS; ORGAN SIZE; X-RAY MICROTOMOGRAPHY;

EID: 77954762253     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.04.600     Document Type: Article

References (41)

1. Moe S., Drueke T., Cunningham J., et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006, 69:1945-1953.
2. Neves K.R., Graciolli F.G., dos Reis L.M., et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 2007, 71:1262-1270.
3. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32:S112-S119.
4. London G.M., Drueke T.B. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997, 51:1678-1695.
5. London G.M., Guerin A.P., Marchais S.J., et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18:1731-1740.
6. Chan D.T., Irish A.B., Dogra G.K., et al. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis 2008, 196:823-834.
7. Sehayek E., Shefer S., Nguyen L.B., et al. Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: studies in C57BL/6 apolipoprotein E knockout mice. Proc Natl Acad Sci USA 2000, 97:3433-3437.
8. Ivanovski O., Nikolov I.G., Joki N., et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis 2009, 205:55-62.
9. Joki N., Nikolov I.G., Caudrillier A., et al. Effects of calcimimetic on vascular calcification and atherosclerosis in uremic mice. Bone 2009, 45(Suppl 1):S30-S34.
10. Massy Z.A., Ivanovski O., Nguyen-Khoa T., et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005, 16:109-116.
11. Phan O., Ivanovski O., Nguyen-Khoa T., et al. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation 2005, 112:2875-2882.
12. Phan O., Ivanovski O., Nikolov I.G., et al. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure. Nephrol Dial Transplant 2008, 23:82-90.
13. Cozzolino M., Mazzaferro S., Pugliese F., et al. Vascular calcification and uremia: what do we know?. Am J Nephrol 2008, 28:339-346.
14. Schilling A.F., Schinke T., Munch C., et al. Increased bone formation in mice lacking apolipoprotein E. J Bone Miner Res 2005, 20:274-282.
15. Dick I.M., Devine A., Marangou A., et al. Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women. Bone 2002, 31:497-502.
16. Kohlmeier M., Saupe J., Schaefer K., et al. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 1998, 62:278-281.
17. Shiraki M., Shiraki Y., Aoki C., et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997, 12:1438-1445.
18. Ivanovski O., Szumilak D., Nguyen-Khoa T., et al. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int 2005, 67:2288-2294.
19. Martin A., David V., Malaval L., et al. Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinology 2007, 148:3419-3425.
20. Ivanovski O., Szumilak D., Nguyen-Khoa T., et al. Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2005, 180:271-276.
21. Ducy P., Desbois C., Boyce B., et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
22. Broedl U.C., Lebherz C., Lehrke M., et al. Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS ONE 2009, 4:e4733.
23. Lee N.K., Sowa H., Hinoi E., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
24. Hirasawa H., Tanaka S., Sakai A., et al. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells. J Bone Miner Res 2007, 22:1020-1030.
25. Salem G.J., Zernicke R.F., Barnard R.J. Diet-related changes in mechanical properties of rat vertebrae. Am J Physiol 1992, 262:R318-R321.
26. Wohl G.R., Loehrke L., Watkins B.A., et al. Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif Tissue Int 1998, 63:74-79.
27. Zernicke R.F., Salem G.J., Barnard R.J., et al. Long-term, high-fat-sucrose diet alters rat femoral neck and vertebral morphology, bone mineral content, and mechanical properties. Bone 1995, 16:25-31.
28. Gonzalez E.A., Lund R.J., Martin K.J., et al. Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int 2002, 61:1322-1331.
29. Boivin G., Farlay D., Bala Y., et al. Influence of remodeling on the mineralization of bone tissue. Osteoporos Int 2009, 20:1023-1026.
30. Parfitt A.M. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 2003, 12:387-403.
31. Huang M.S., Lu J., Ivanov Y., et al. Hyperlipidemia impairs osteoanabolic effects of PTH. J Bone Miner Res 2008, 23:1672-1679.
32. Farhat G.N., Cauley J.A., Matthews K.A., et al. Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res 2006, 21:1839-1846.
33. Hak A.E., Pols H.A., van Hemert A.M., et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000, 20:1926-1931.
34. Kiel D.P., Kauppila L.I., Cupples L.A., et al. Bone loss and the progression of abdominal aortic calcification over a 25year period: the Framingham Heart Study. Calcif Tissue Int 2001, 68:271-276.
35. Min H., Morony S., Sarosi I., et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 2000, 192:463-474.
36. Samelson E.J., Kiel D.P., Broe K.E., et al. Metacarpal cortical area and risk of coronary heart disease: the Framingham Study. Am J Epidemiol 2004, 159:589-595.
37. Braun J., Oldendorf M., Moshage W., et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996, 27:394-401.
38. London G.M., Marty C., Marchais S.J., et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004, 15:1943-1951.
39. Rodriguez-Garcia M., Gomez-Alonso C., Naves-Diaz M., et al. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant 2009, 24:239-246.
40. Krueger T., Westenfeld R., Ketteler M., Schurgers L.J., Floege J. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?. Kidney Int 2009, 76:18-22.
41. Davies M.R., Lund R.J., Mathew S., et al. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 2005, 16:917-928.